Valuation: PolyPeptide Group AG

Market Cap 1.51B 1.68B 1.39B 1.26B 2.35B 160B 2.39B 16.54B 6.64B 84.07B 6.32B 6.18B 265B P/E 2026 *
56.2x
P/E 2027 * 29.8x
Enterprise Value 1.61B 1.8B 1.48B 1.34B 2.51B 171B 2.55B 17.64B 7.08B 89.7B 6.74B 6.6B 283B EV / Sales 2026 *
3.2x
EV / Sales 2027 * 2.84x
Free-Float
39.12%
Yield 2026 *
-
Yield 2027 * 0.14%
1 day-3.23%
1 week-4.44%
1 month-4.76%
3 months-4.11%
6 months+10.09%
Current year+60.92%
1 week 41.7
Extreme 41.7
43.95
1 month 41.7
Extreme 41.7
44.3
Current year 23.1
Extreme 23.1
50.1
1 year 21.8
Extreme 21.8
50.1
3 years 13.22
Extreme 13.22
50.1
5 years 13.22
Extreme 13.22
146
10 years 13.22
Extreme 13.22
147.4
Manager TitleAgeSince
Chief Executive Officer 54 2023-04-11
Director of Finance/CFO 54 2024-01-01
Chief Tech/Sci/R&D Officer 54 -
Director TitleAgeSince
Director/Board Member 73 2005-12-31
Chairman 69 2021-03-31
Director/Board Member 62 2020-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
11/13/23 Buy 2,500 0.0075%
10/12/23 Buy 159,959 0.4829%
4/6/23 Buy 45,842 0.1384%
Change 5-day change 1-year change 3-year change Capi.($)
-3.23%-4.44%+61.54%+146.77% 1.68B
+3.19%+11.31%+64.28%+155.91% 1,263B
-0.73%+3.56%+44.65%+84.17% 658B
+1.41%+3.24%+35.25%+108.88% 521B
+0.42%+3.20%+55.81%+72.50% 391B
+2.18%+2.93%+73.90%+45.59% 369B
+1.12%+4.52%+34.76%+58.24% 307B
+6.96%+8.86%+11.95%+36.20% 290B
+1.15%+6.09%+56.15%+82.25% 252B
+3.06%+9.38%+42.48%+117.32% 212B
Average +1.55%+4.86%+48.08%+90.78% 426.36B
Weighted average by Cap. +2.00%+6.59%+50.51%+100.45%

Financials

2026 *2027 *
Net sales 502M 560M 462M 418M 782M 53.21B 797M 5.51B 2.21B 27.99B 2.1B 2.06B 88.28B 576M 643M 530M 480M 897M 61.07B 914M 6.32B 2.54B 32.12B 2.41B 2.36B 101B
Net income 23.5M 26.24M 21.62M 19.59M 36.62M 2.49B 37.3M 258M 104M 1.31B 98.49M 96.4M 4.13B 45.23M 50.5M 41.6M 37.7M 70.46M 4.8B 71.78M 496M 199M 2.52B 190M 185M 7.95B
Net Debt 101M 113M 92.86M 84.14M 157M 10.7B 160M 1.11B 445M 5.63B 423M 414M 17.76B 131M 146M 120M 109M 204M 13.88B 208M 1.44B 576M 7.3B 549M 537M 23.02B
Projected Income Statement - Annual - PolyPeptide Group AG
Logo PolyPeptide Group AG
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Employees
1,460
Date Price Change Volume
26-10-30 CHF 42.00 -3.23% 49,489
26-10-29 CHF 43.40 -0.69% 8,308
26-10-28 CHF 43.70 -0.23% 20,064
26-10-27 CHF 43.80 -.--% 17,714
26-10-26 CHF 43.80 -0.34% 17,921
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - PolyPeptide Group AG
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
45.66EUR
Average target price
46.11EUR
Spread / Average Target
+0.99%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - PolyPeptide Group AG
  1. Stock Market
  2. Stocks
  3. PPGN Stock